Vaidya Sane Ayurved Laboratories P/E Ratio
Current P/E Ratio
21.12
Moderate Valuation
High - Growth expectations or overvalued
Vaidya Sane Ayurved Laboratories (MADHAVBAUG) P/E ratio is 21.12 (Moderate), EPS (TTM) ₹8.51, current price ₹ on None — High - Growth expectations or overvalued. Read Vaidya Sane Ayurved Laboratori dividend payments for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
21.12
Current Price
₹
EPS (TTM)
₹8.51
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.43
Sector Median
31.4
Sector Rank
#11 of 194
Sector Percentile
5.7%
Earnings Breakdown (TTM)
TTM EPS
₹8.32
Sept 2023
₹1.12
Jun 2023
₹2.60
MADHAVBAUG P/E Ratio — Valuation Signal & Historical Context
Vaidya Sane Ayurved Laboratories P/E 21.12 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see MADHAVBAUG screener.
- Trading at discount to sector average PE of 55.43
MADHAVBAUG vs Healthcare Peers — P/E Ratio Comparison
Vaidya Sane Ayurved Laboratories P/E 21.12 vs Healthcare average 55.43, median 31.4 — range 2.86–987.08.
Sector Average
55.43
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
987.08
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |